rs179363890
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PS1_ModeratePM2PP3_StrongPP5_Moderate
The NM_000101.4(CYBA):āc.155T>Cā(p.Leu52Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000248 in 1,610,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt.
Frequency
Consequence
NM_000101.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYBA | NM_000101.4 | c.155T>C | p.Leu52Pro | missense_variant | 3/6 | ENST00000261623.8 | NP_000092.2 | |
CYBA | XM_011522905.4 | c.155T>C | p.Leu52Pro | missense_variant | 3/6 | XP_011521207.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYBA | ENST00000261623.8 | c.155T>C | p.Leu52Pro | missense_variant | 3/6 | 1 | NM_000101.4 | ENSP00000261623.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152138Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000408 AC: 1AN: 245088Hom.: 0 AF XY: 0.00000751 AC XY: 1AN XY: 133226
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1458662Hom.: 0 Cov.: 33 AF XY: 0.00000276 AC XY: 2AN XY: 725718
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152138Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74316
ClinVar
Submissions by phenotype
not provided Pathogenic:1Other:1
not provided, no classification provided | literature only | UniProtKB/Swiss-Prot | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 18, 2015 | The L52P variant in the CYBA gene has been reported previously in the apparently homozygous state inan individual with chronic granulomatous disease (Rae et al., 2000). The L52P substitution was not observedin approximately 6,500 individuals of European and African American ancestry in the NHLBI ExomeSequencing Project, indicating it is not a common benign variant in these populations. The L52P variant isa semi-conservative amino acid substitution, which may impact secondary protein structure as theseresidues differ in some properties. This substitution occurs at a position that is conserved across species. Insilico analysis predicts this variant is probably damaging to the protein structure/function. Missensevariants in nearby residues (L51Q, E53V, P55R) have been reported in the Human Gene MutationDatabase in association with chronic granulomatous disease (Stenson et al., 2014), supporting thefunctional importance of this region of the protein. We interpret L52P as a pathogenic variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at